Medicare Enrolled
Dr. Christopher Mizelle, MD
Dermatology · New Bern, NC
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mizelle from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mizelle?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mizelle
Dr. Christopher Mizelle is a dermatology specialist in New Bern, NC, with 19 years of NPI registration. Based on federal Medicare data, Dr. Mizelle performed 24,017 Medicare services across 9,511 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mizelle received a total of $7,567 from 42 pharmaceutical and/or device companies across 381 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mizelle is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 1% volume in NC
$7,567 industry payments
Medicare Practice Summary
Medicare Utilization ↗24,017
Medicare services
Top 1% in NC for dermatology
9,511
Unique beneficiaries
$39
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,264 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
10,279 | $5 | $20 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,963 | $58 | $200 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
2,375 | $30 | $145 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
1,387 | $60 | $235 |
| Ultraviolet light skin treatment Application of ultraviolet light to the skin for therapeutic purposes. |
1,321 | $17 | $59 |
| Shaving of skin growth on face, 0.6-1.0 cm This procedure involves shaving off a skin growth located on the face, ears, eyelids, nose, lips, or mouth. The size of the growth being removed is between 0.6 and 1.0 centimeters. |
575 | $84 | $270 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
549 | $1 | $5 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
444 | $118 | $300 |
| Shaving of skin growth, 0.6-1.0 cm A minor procedure to shave off a skin growth on the body, arms, or legs that measures between 0.6 and 1.0 centimeters. |
392 | $70 | $240 |
| Destruction of cancer skin growth, 1.1-2.0 cm Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters. |
319 | $110 | $359 |
| Shaving of skin growth, 0.6-1.0 cm A minor procedure to shave off a skin growth measuring 0.6 to 1.0 cm from the scalp, neck, hands, feet, or genitals. |
274 | $73 | $238 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
265 | $37 | $125 |
| Surgical removal of facial skin cancer, 1.1-2.0 cm This procedure involves the surgical excision of a cancerous skin growth located on the face, ears, eyelids, nose, lips, or mouth. The size of the removed tissue is between 1.1 and 2.0 centimeters. |
198 | $101 | $529 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
198 | $10 | $50 |
| Intermediate wound repair, 2.6-7.5 cm A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing. |
188 | $217 | $592 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
185 | $8 | $55 |
| Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | 164 | $228 | $581 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
150 | $50 | $191 |
| Shaving of skin growth, 1.1-2.0 cm This procedure involves shaving off a skin growth measuring between 1.1 and 2.0 centimeters from the body, arms, or legs. |
142 | $83 | $280 |
| Topical aminolevulinic acid HCl 20% solution A topical medication applied to the skin for medical treatment. It is supplied as a single-unit dosage form containing 354 mg of the active ingredient. |
123 | $303 | $475 |
| Light therapy to destroy precancerous skin growth This procedure uses light to treat and remove precancerous skin lesions. It is a method for destroying abnormal skin cells before they become cancerous. |
108 | $97 | $250 |
| Shaving of small skin growth on face or mouth area A minor procedure to shave off a small skin growth, measuring 0.5 cm or less, located on the face, ears, eyelids, nose, lips, or mouth. |
95 | $66 | $221 |
| Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | 93 | $128 | $395 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
86 | $85 | $275 |
| Shaving of skin growth, 1.1-2.0 cm Removal of a skin growth by shaving the surface. The procedure is performed on the scalp, neck, hands, feet, or genitals and involves a lesion measuring between 1.1 and 2.0 centimeters. |
85 | $88 | $269 |
| Shaving of skin growth, 1.1-2.0 cm Removal of a skin growth by shaving the surface of the skin. The procedure is performed on the face, ears, eyelids, nose, lips, or mouth and involves a lesion measuring between 1.1 and 2.0 centimeters. |
84 | $103 | $310 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring between 1.1 and 2.0 centimeters on the body, arms, or legs. |
78 | $92 | $480 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
73 | $72 | $225 |
| Surgical removal of skin cancer, 2.1-3.0 cm This procedure involves the surgical excision of a cancerous skin growth located on the body, arms, or legs. The size of the removed tissue measures between 2.1 and 3.0 centimeters. |
61 | $108 | $555 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring 1.1 to 2.0 centimeters from the scalp, neck, hands, feet, or genitals. |
56 | $96 | $511 |
| Intermediate wound repair, 2.6-7.5 cm This procedure involves stitching a wound on the neck, hands, feet, or genitals that measures between 2.6 and 7.5 centimeters. It is classified as an intermediate repair requiring layered closure. |
50 | $226 | $585 |
| Destruction of cancerous skin growth on face, 1.1-2.0 cm This procedure involves the removal or destruction of a cancerous skin lesion located on the face, ears, eyelids, nose, lips, or mouth. The lesion treated measures between 1.1 and 2.0 centimeters in diameter. |
50 | $139 | $405 |
| Destruction of cancer skin growth, 0.6-1.0 cm This procedure involves the removal or destruction of a cancerous skin growth located on the trunk, arms, or legs that measures between 0.6 and 1.0 centimeters. |
49 | $86 | $305 |
| Removal of noncancer skin growth, 1.1-2.0 cm This procedure involves the surgical removal of a benign skin growth located on the body, arms, or legs. The growth measured between 1.1 and 2.0 centimeters in diameter. |
43 | $65 | $325 |
| Skin graft repair, 10 sq cm or less A surgical procedure to repair a wound by transferring a small piece of skin to the affected area. The graft covers wounds on the face, neck, hands, feet, or other specified body parts. |
43 | $563 | $1,468 |
| Punch biopsy of first skin growth A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination. |
37 | $82 | $250 |
| Destruction of skin growth, 15 or more growths | 37 | $68 | $275 |
| Punch biopsy of additional skin growth A small circular tool is used to remove a sample of an extra skin growth for laboratory examination. |
36 | $45 | $130 |
| Destruction of cancerous skin growth on face, 0.6-1.0 cm This procedure involves the removal or destruction of a cancerous skin lesion located on the face, ears, eyelids, nose, lips, or mouth. The lesion treated measures between 0.6 and 1.0 centimeters in diameter. |
36 | $126 | $400 |
| Intermediate wound repair, 7.6-12.5 cm This procedure involves stitching a wound on the scalp, underarms, trunk, arms, or legs that measures between 7.6 and 12.5 centimeters. It includes cleaning the wound and closing it with sutures to promote healing. |
34 | $253 | $632 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
31 | $22 | $111 |
| Destruction of cancerous skin growth, 2.1-3.0 cm This procedure involves the removal or destruction of a cancerous skin lesion measuring between 2.1 and 3.0 centimeters located on the trunk, arms, or legs. |
28 | $126 | $395 |
| Intermediate wound repair, face or mouth, 2.5 cm or less A medical procedure to close a wound on the face, ears, eyelids, nose, lips, or mouth that is 2.5 centimeters or smaller. This type of repair involves more than simple closure but is less complex than a major repair. |
27 | $201 | $511 |
| Skin growth shaving, 0.5 cm or less This procedure involves shaving off a small skin growth measuring 0.5 centimeters or less from the body, arms, or legs. |
24 | $44 | $200 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
23 | $38 | $111 |
| Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 5.1-7.5 cm | 22 | $277 | $675 |
| Surgical removal of skin cancer, 2.1-3.0 cm Surgical excision of a cancerous skin growth measuring 2.1 to 3.0 centimeters from the scalp, neck, hands, feet, or genitals. |
20 | $113 | $582 |
| All potassium hydroxide (koh) preparations | 19 | $6 | $55 |
| Ear tissue biopsy A procedure to remove a small sample of tissue from the ear for laboratory examination. |
18 | $42 | $210 |
| Tuberculosis skin test A small amount of fluid is injected under the skin to check for a reaction that indicates exposure to tuberculosis bacteria. |
17 | $6 | $22 |
| Removal of noncancer skin growth, 0.6-1.0 cm This procedure involves the removal of a benign skin growth located on the body, arms, or legs. The growth removed measures between 0.6 and 1.0 centimeters in diameter. |
16 | $86 | $295 |
| Destruction of cancer skin growth, 0.6-1.0 cm This procedure involves the removal or destruction of a cancerous skin growth measuring 0.6 to 1.0 centimeters. It is performed on the scalp, neck, hands, feet, or genitals. |
13 | $97 | $352 |
| Removal of noncancer skin growth, 2.1-3.0 cm This procedure involves the surgical removal of a benign skin growth located on the body, arms, or legs. The excised tissue measures between 2.1 and 3.0 centimeters in diameter. |
12 | $75 | $380 |
| Skin cancer removal, face/ears/eyes/nose/lips, 2.1-3.0 cm Surgical removal of a cancerous skin growth from the face, ears, eyelids, nose, lips, or mouth. The procedure involves excising a lesion measuring between 2.1 and 3.0 centimeters. |
11 | $120 | $622 |
| Intermediate wound repair, 2.5 cm or less This procedure involves stitching a wound on the scalp, underarms, trunk, arms, or legs that is 2.5 centimeters or smaller. It includes cleaning the wound and closing it with sutures to promote healing. |
11 | $191 | $475 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$7,567
Total received (2018-2024)
Avg $1,081/year across 7 years
Top 23% in NC for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
381
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,051 (93.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$516 (6.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,432
2023
$1,502
2022
$1,300
2021
$905
2020
$248
2019
$1,300
2018
$880
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$332
SUN PHARMACEUTICAL INDUSTRIES INC.
$206
LEO Pharma Inc.
$166
ABBVIE INC.
$159
Regeneron Healthcare Solutions, Inc.
$109
Novartis Pharmaceuticals Corporation
$109
Organogenesis Inc.
$92
E.R. Squibb & Sons, L.L.C.
$83
Boehringer Ingelheim Pharmaceuticals, Inc.
$67
REVANCE THERAPEUTICS, INC.
$58
Verrica Pharmaceuticals Inc.
$18
UCB, Inc.
$18
PFIZER INC.
$15
Top 3 companies account for 49.2% of 2024 payments
All-time payments by company (2018-2024) ›
Merz North America, Inc.
$1,209
Janssen Biotech, Inc.
$992
ABBVIE INC.
$800
Sun Pharmaceutical Industries Inc.
$487
PFIZER INC.
$389
Novartis Pharmaceuticals Corporation
$357
SUN PHARMACEUTICAL INDUSTRIES INC.
$322
LEO Pharma Inc.
$310
AbbVie Inc.
$270
Regeneron Healthcare Solutions, Inc.
$237
GENZYME CORPORATION
$199
AbbVie, Inc.
$198
E.R. Squibb & Sons, L.L.C.
$180
MERZ NORTH AMERICA, INC.
$177
Boehringer Ingelheim Pharmaceuticals, Inc.
$166
Lilly USA, LLC
$151
Organogenesis Inc.
$138
PruGen, Inc. Pharmaceuticals
$127
Allergan, Inc.
$105
Galderma Laboratories, L.P.
$96
Almirall LLC
$91
Helsinn Therapeutics (U.S.), Inc.
$90
Biofrontera Inc.
$60
REVANCE THERAPEUTICS, INC.
$58
Genentech USA, Inc.
$44
DUSA Pharmaceuticals, Inc.
$37
UCB, Inc.
$31
Allergan Inc.
$31
NOVARTIS PHARMACEUTICALS CORPORATION
$22
Aclaris Therapeutics, Inc.
$21
Dermavant Sciences, Inc.
$20
Verrica Pharmaceuticals Inc.
$18
Incyte Corporation
$16
EPI Health, LLC
$16
Taro Pharmaceuticals USA, Inc.
$16
Sandoz Inc.
$14
VYNE Pharmaceuticals Inc.
$13
Journey Medical Corporation
$12
STRATA Skin Sciences, Inc.
$12
Melinta Therapeutics, Inc.
$12
Amgen Inc.
$11
TARO PHARMACEUTICALS USA, INC.
$11
Top 3 companies account for 39.7% of all-time payments
Associated products mentioned in payments ›
20% · ABSORICA · ABSORICA (isotretinoin) · ABSORICA LD · ADBRY · AKLIEF · AMELUZ · AMZEEQ · Absorica LD · BLU-U · BOTOX · BOTOX COSMETIC · Baxdela · Bensal HP · Bimzelx · COSENTYX · Cimzia · Cordran · DAXXIFY · DUPIXENT · Dermatological Psoriasis and Vitiligo Treatment · ENSTILAR · EUCRISA · Enbrel · Erivedge · HALOG (Halcinonide Cream · HUMIRA · HYRIMOZ · Humira · ILUMYA · Ilumya · Klisyri · LEVULAN KERASTICK · LIBTAYO · Levulan Kerastick (aminolevulinic acid HCl) for Topical Solution · OPZELURA · Puraply · QBREXZA · REMICADE · RHOFADE · RINVOQ · SKYRIZI · SPEVIGO · Seysara · Skyrizi · Sotyktu · TALTZ · TREMFYA · Tremfya · ULTRAVATE · USP) 0.1% · VALCHLOR · VTAMA · Veltin · Winlevi · XELJANZ · Xolair · YCANTH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (93%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Dermatologists within 10 mi
7
Per 100K population
6.9
County median income
$64,635
Nearest hospital
CAROLINA EAST MEDICAL CENTER
8.9 mi
8.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mizelle is a mixed practice specialist, with above-average Medicare volume (top 1% in NC), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mizelle experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Mizelle performed 10,279 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mizelle receive payments from pharmaceutical companies?
Yes. Dr. Mizelle received a total of $7,567 from 42 companies across 381 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mizelle's costs compare to other dermatologists in New Bern?
Dr. Mizelle's average Medicare payment per service is $39. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mizelle) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Dermatologists in New Bern
Browse dermatologists in New Bern ranked by procedure volume and transparency data.
Highest volume
Top Dermatologists in NC
Dermatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatologists in NC
Which NC dermatologists receive the most from drug and device companies.
By company
Merz North America, Inc. Payments to Doctors
See all physicians who received payments from Merz North America, Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology